Adoptive cellular therapy improves Parkinson’s symptoms in mouse-model study
UF neuroscientists provide preclinical evidence for adoptive cellular therapy as a potential immunotherapy treatment to improve symptoms in genetic form of Parkinson’s.
Posted in
MBI News
UF neurosurgeon appointed assistant dean of revenue cycle management
Dr. Daniel Hoh appointed to new leadership role.
Treatment to strengthen cough shows promise for Parkinson’s patients
Study co-authored by Dr. Karen Hegland found sensorimotor training for airway protection improved cough-related outcomes in Parkinson’s patients.
Innovative immunotherapy for malignant brain tumors
Research spotlight focuses on Dr. Duane Mitchell, winner of the 2022 Clinical Science Research Award.
Experts provide clinical guidance amid rise in sudden-onset tic-like symptoms
UF neurologist Dr. Irene Malaty and international experts publish review on diagnosis and management of functional tic-like phenomena.
Does replacing dopamine help with facial masking in PD?
Dr. Dawn Bowers and Rachel Schade led study reporting that dopamine medications improves facial movement and expressions in Parkinson’s.
NFL partners with UF to measure on-field head impacts using mouthguard sensors
Dr. Jay Clugston and colleagues will lead UF’s research efforts as part of multi-institutional effort.
MBI members appointed College of Medicine assistant deans for research
Drs. Elias Sayour and Daniel Wesson appointed to new leadership roles.
Researchers receive $3.6M grant to study breathing therapy for spinal cord injury
Dr. Emily Fox will lead study evaluating ways to optimize intermittent hypoxia therapy.
UF neuroscientists publish review of latest Tourette syndrome research
Multicenter data sharing has enabled recent advances in understanding the genetics and pathophysiology of the neurodevelopmental disorder.
